MilliporeSigma Webinars

  1. Maximizing The Value Of Your AAV Using Small Volume AAV Testing 8/11/2023

    Learn about an approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.

  2. How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing 7/26/2023

    To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.

  3. Streamlining Viral Vector Development And Gene Therapy Manufacturing 7/19/2023

    Explore solutions for gene therapy production from experts, as they highlight the key features of a GMP manufacturing facility, including its technologies and infrastructure, through a virtual tour.

  4. Vaccine Journey: Bench To Market 7/19/2023

    Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.

  5. Automated Data Integrity In Sterility Testing 7/10/2023

    Explore trends and challenges in microbiology QC with Anne Weeks, a senior field marketing manager at MilliporeSigma. She discusses workflow automation and introduces a customizable MTR solution.

  6. A Single-Use, Scale-Down, Predictive Solution For Intensified Perfusion Development 6/23/2023

    Here, we describe a new microbioreactor system that fulfills the throughput-performance gap, providing single-use, perfusion bioreactors that can replicate bench-scale perfusion processes at industrially relevant cell densities.

  7. How Crucial Is Culture Media Selection In Environmental Monitoring? 6/20/2023

    Explore culture media regulatory requirements, the impact of manufacturing guidelines and media features and specifications on environmental monitoring, and the importance of media supplier selection.

  8. Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development 6/12/2023

    To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.

  9. The Route To Faster Microbial Quality Control 6/7/2023

    Join product and application experts Anne-Grit Klees, Carine Krebs, and Esther Welterlin to discover the benefits of using a new rapid microbial detection platform.

  10. Establishing Analytical Methods For Emerging mRNA-Based Therapies 6/5/2023

    Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.